Alonso Krangle LLP continues to offer free yaz blood clot lawsuit evaluations and yasmin blood clot lawsuit evaluations to alleged victims of Yaz and Yasmin side effects!
Melville NY (PRWEB) April 11, 2012
Attorneys Andres Alonso and David Krangle, founding partners of Alonso Krangle LLP, a national law firm focused on fighting for the rights of serious personal injury victims, are alerting consumers to new information about blood clot risks that is being added to the labels of Yaz, Yasmin and similar birth control pills. The U.S. Food & Drug Administration (FDA) announced on April 10, 2012, that has completed its review of recent observational (epidemiologic) studies regarding the risk of blood clots in women taking drospirenone-containing birth control pills, including Yaz and Yasmin. Based on this review, the FDA has concluded that drospirenone-containing birth control pills may be associated with a higher risk of blood clots than other progestin-containing pills
- Blood clots
- Deep vein thrombosis
- Pulmonary Embolism
- Heart attack
- Sudden death
To discuss a potential Yaz lawsuit or Yasmin lawsuit claim with one of the experienced and compassionate defective drug lawyers at Alonso Krangle LLP, please contact us at 1-800-403-6191 or visit our website, FightForVictims.com.
Yaz, Yasmin and similar contraceptives are made with a fourth-generation synthetic progestin called drospirenone. In December 2011, a panel of FDA advisors voted 21-5 to recommend that labels for Yaz, Yasmin and similar pills be updated with stronger warnings about their possible potential to cause serious, life threatening blood clots. In a much closer vote (15 to 11), the advisors recommended that Yaz and Yasmin should remain on the market. [vitals.msnbc.msn.com/_news/2011/12/08/9307469-fda-panel-add-stronger-warnings-to-birth-control-labels]
In its April 10 Drug Safety Communication, the FDA said the new label will state that some epidemiologic studies reported as much as a three-fold increase in the risk of blood clots for drospirenone birth control pills when compared to products containing levonorgestrel or some other progestins, whereas other epidemiological studies found no additional risk of blood clots with drospirenone-containing products. The labels also will include a summary of an FDA-funded study of the blood clot risk, which was released last fall. That study suggested an approximately 1.5-fold increase in the risk of blood clots for women who use drospirenone-containing birth control pills compared to users of other hormonal contraceptives. [fda.gov/Drugs/DrugSafety/ucm273021.htm]
In addition to Yaz and Yasmin, the new information will be added to other drospirenone-containing birth control pills, including Beyaz, Gianvi, Loryna, Ocella, Safyral, Syeda, and Zarah, as well as generic versions.
Yaz and Yasmin Lawsuits
More than 10,000 personal injury lawsuits that allege Yaz, Yasmin and other drospirenone-containing birth control pills are currently pending in the Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100) in the U.S. District Court for the Southern District of Illinois before the Honorable Judge David Herndon. Andres Alonso is serving as a member of the Plaintiffs’ Steering Committee in that litigation.
There is still time for young women who may have been injured by Yaz and Yasmin to file lawsuits in this litigation. To discuss a potential claim with one of the experienced and compassionate Yaz and Yasmin injury lawyers at Alonso Krangle LLP, please contact us at 1-800-403-6191 or visit our website FightForVictims.com
About Alonso Krangle LLP
Andres Alonso and David Krangle, attorneys with almost 40 years of collective legal experience, have focused their law practice on the handling of significant personal injury cases, defective drug cases including Actos bladder cancer lawsuits, Fosamax Femur Fracture Lawsuits, Zoloft Lawsuit s, and medical device litigation, construction site accidents, nursing home abuse, medical negligence, qui tam/whistleblower actions and consumer fraud cases. A national law firm representing injured victims throughout the U.S., Alonso Krangle LLP is headquartered in Long Island, New York, with offices in New York City, and plans to open additional locations in New Jersey.
For more information about Alonso Krangle or to join the fight and be a part of our team, please contact us at 1-800-403-6191 or visit our website, http://www.FightForVictims.com
Contact: Alonso Krangle LLP
445 Broad Hollow Road
Melville, New York